[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fNxJJKaL5GgguzFWAYVi-cbZUqWik9Ppt04DCvCcBKL8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"Medtronic - MITG",[4],178,false,11,5,281266,0,174,[14,17,20,22,25,27,29,31],{"name":15,"count":16},"Colonic Diseases",9,{"name":18,"count":19},"Hypoxia",8,{"name":21,"count":19},"Healthy",{"name":23,"count":24},"Anesthesia",6,{"name":26,"count":9},"Diabetes",{"name":28,"count":9},"Crohn's Disease",{"name":30,"count":9},"Ventral Hernia",{"name":32,"count":33},"Healthy Subjects",4,[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[43,73,91,109,127,151,183,201,219,237,255,273,291],{"intervention":44,"totalTrials":45,"cells":46},"Saline 0.06 ml\u002Fkg",1,{"EARLY_PHASE1":47,"PHASE1":49,"PHASE2":51,"PHASE3":53,"PHASE4":55,"NA":57},{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[],{"trials":56,"activeCount":11},[],{"trials":58,"activeCount":11},[59],{"nctId":60,"briefTitle":61,"status":62,"phases":63,"primaryCompletion":64,"completion":64,"start":65,"enrollment":66,"conditions":67,"interventions":69},"NCT01450813","The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy","COMPLETED",[41],"2013-12","2009-06",80,[23,68],"Neuromuscular Blockade",[44,70,71,72],"Rocuronium 0.2 mg\u002Fkg","Rocuronium 0.4 mg\u002Fkg","Rocuronium 0.6 mg\u002Fkg",{"intervention":70,"totalTrials":45,"cells":74},{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":85},{"trials":76,"activeCount":11},[],{"trials":78,"activeCount":11},[],{"trials":80,"activeCount":11},[],{"trials":82,"activeCount":11},[],{"trials":84,"activeCount":11},[],{"trials":86,"activeCount":11},[87],{"nctId":60,"briefTitle":61,"status":62,"phases":88,"primaryCompletion":64,"completion":64,"start":65,"enrollment":66,"conditions":89,"interventions":90},[41],[23,68],[44,70,71,72],{"intervention":71,"totalTrials":45,"cells":92},{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":103},{"trials":94,"activeCount":11},[],{"trials":96,"activeCount":11},[],{"trials":98,"activeCount":11},[],{"trials":100,"activeCount":11},[],{"trials":102,"activeCount":11},[],{"trials":104,"activeCount":11},[105],{"nctId":60,"briefTitle":61,"status":62,"phases":106,"primaryCompletion":64,"completion":64,"start":65,"enrollment":66,"conditions":107,"interventions":108},[41],[23,68],[44,70,71,72],{"intervention":72,"totalTrials":45,"cells":110},{"EARLY_PHASE1":111,"PHASE1":113,"PHASE2":115,"PHASE3":117,"PHASE4":119,"NA":121},{"trials":112,"activeCount":11},[],{"trials":114,"activeCount":11},[],{"trials":116,"activeCount":11},[],{"trials":118,"activeCount":11},[],{"trials":120,"activeCount":11},[],{"trials":122,"activeCount":11},[123],{"nctId":60,"briefTitle":61,"status":62,"phases":124,"primaryCompletion":64,"completion":64,"start":65,"enrollment":66,"conditions":125,"interventions":126},[41],[23,68],[44,70,71,72],{"intervention":128,"totalTrials":45,"cells":129},"Methylene Blue",{"EARLY_PHASE1":130,"PHASE1":132,"PHASE2":134,"PHASE3":136,"PHASE4":138,"NA":140},{"trials":131,"activeCount":11},[],{"trials":133,"activeCount":11},[],{"trials":135,"activeCount":11},[],{"trials":137,"activeCount":11},[],{"trials":139,"activeCount":11},[],{"trials":141,"activeCount":11},[142],{"nctId":143,"briefTitle":144,"status":62,"phases":145,"primaryCompletion":146,"completion":146,"start":147,"enrollment":66,"conditions":148,"interventions":150},"NCT01539135","The Influence of Endotracheal Tube Design on Fluid Leakage Into the Lungs During Surgery",[41],"2013-05","2012-04",[149],"Respiratory Aspiration",[128],{"intervention":152,"totalTrials":45,"cells":153},"Senna",{"EARLY_PHASE1":154,"PHASE1":156,"PHASE2":158,"PHASE3":160,"PHASE4":162,"NA":164},{"trials":155,"activeCount":11},[],{"trials":157,"activeCount":11},[],{"trials":159,"activeCount":11},[],{"trials":161,"activeCount":11},[],{"trials":163,"activeCount":11},[],{"trials":165,"activeCount":11},[166],{"nctId":167,"briefTitle":168,"status":62,"phases":169,"primaryCompletion":170,"completion":171,"start":172,"enrollment":173,"conditions":174,"interventions":176},"NCT02481219","Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure",[41],"2016-01","2016-02","2015-05",122,[175],"Colorectal Cancer Screening",[152,177,178,179,180,181,182],"PEG","Metoclopramide","Erythromycin","SUPREP oral sulfate solution","Bisacodyl","SUPREP oral sulfate solution with Gastrografin",{"intervention":177,"totalTrials":45,"cells":184},{"EARLY_PHASE1":185,"PHASE1":187,"PHASE2":189,"PHASE3":191,"PHASE4":193,"NA":195},{"trials":186,"activeCount":11},[],{"trials":188,"activeCount":11},[],{"trials":190,"activeCount":11},[],{"trials":192,"activeCount":11},[],{"trials":194,"activeCount":11},[],{"trials":196,"activeCount":11},[197],{"nctId":167,"briefTitle":168,"status":62,"phases":198,"primaryCompletion":170,"completion":171,"start":172,"enrollment":173,"conditions":199,"interventions":200},[41],[175],[152,177,178,179,180,181,182],{"intervention":178,"totalTrials":45,"cells":202},{"EARLY_PHASE1":203,"PHASE1":205,"PHASE2":207,"PHASE3":209,"PHASE4":211,"NA":213},{"trials":204,"activeCount":11},[],{"trials":206,"activeCount":11},[],{"trials":208,"activeCount":11},[],{"trials":210,"activeCount":11},[],{"trials":212,"activeCount":11},[],{"trials":214,"activeCount":11},[215],{"nctId":167,"briefTitle":168,"status":62,"phases":216,"primaryCompletion":170,"completion":171,"start":172,"enrollment":173,"conditions":217,"interventions":218},[41],[175],[152,177,178,179,180,181,182],{"intervention":179,"totalTrials":45,"cells":220},{"EARLY_PHASE1":221,"PHASE1":223,"PHASE2":225,"PHASE3":227,"PHASE4":229,"NA":231},{"trials":222,"activeCount":11},[],{"trials":224,"activeCount":11},[],{"trials":226,"activeCount":11},[],{"trials":228,"activeCount":11},[],{"trials":230,"activeCount":11},[],{"trials":232,"activeCount":11},[233],{"nctId":167,"briefTitle":168,"status":62,"phases":234,"primaryCompletion":170,"completion":171,"start":172,"enrollment":173,"conditions":235,"interventions":236},[41],[175],[152,177,178,179,180,181,182],{"intervention":180,"totalTrials":45,"cells":238},{"EARLY_PHASE1":239,"PHASE1":241,"PHASE2":243,"PHASE3":245,"PHASE4":247,"NA":249},{"trials":240,"activeCount":11},[],{"trials":242,"activeCount":11},[],{"trials":244,"activeCount":11},[],{"trials":246,"activeCount":11},[],{"trials":248,"activeCount":11},[],{"trials":250,"activeCount":11},[251],{"nctId":167,"briefTitle":168,"status":62,"phases":252,"primaryCompletion":170,"completion":171,"start":172,"enrollment":173,"conditions":253,"interventions":254},[41],[175],[152,177,178,179,180,181,182],{"intervention":181,"totalTrials":45,"cells":256},{"EARLY_PHASE1":257,"PHASE1":259,"PHASE2":261,"PHASE3":263,"PHASE4":265,"NA":267},{"trials":258,"activeCount":11},[],{"trials":260,"activeCount":11},[],{"trials":262,"activeCount":11},[],{"trials":264,"activeCount":11},[],{"trials":266,"activeCount":11},[],{"trials":268,"activeCount":11},[269],{"nctId":167,"briefTitle":168,"status":62,"phases":270,"primaryCompletion":170,"completion":171,"start":172,"enrollment":173,"conditions":271,"interventions":272},[41],[175],[152,177,178,179,180,181,182],{"intervention":182,"totalTrials":45,"cells":274},{"EARLY_PHASE1":275,"PHASE1":277,"PHASE2":279,"PHASE3":281,"PHASE4":283,"NA":285},{"trials":276,"activeCount":11},[],{"trials":278,"activeCount":11},[],{"trials":280,"activeCount":11},[],{"trials":282,"activeCount":11},[],{"trials":284,"activeCount":11},[],{"trials":286,"activeCount":11},[287],{"nctId":167,"briefTitle":168,"status":62,"phases":288,"primaryCompletion":170,"completion":171,"start":172,"enrollment":173,"conditions":289,"interventions":290},[41],[175],[152,177,178,179,180,181,182],{"intervention":292,"totalTrials":45,"cells":293},"Bowel prep combination",{"EARLY_PHASE1":294,"PHASE1":296,"PHASE2":298,"PHASE3":300,"PHASE4":302,"NA":304},{"trials":295,"activeCount":11},[],{"trials":297,"activeCount":11},[],{"trials":299,"activeCount":11},[],{"trials":301,"activeCount":11},[],{"trials":303,"activeCount":11},[],{"trials":305,"activeCount":11},[306],{"nctId":307,"briefTitle":308,"status":309,"phases":310,"primaryCompletion":311,"completion":312,"start":313,"enrollment":314,"conditions":315,"interventions":316},"NCT03301909","Development of Applications of PillCam™ Endoscopy and Patency Systems and Clinical Evaluation of Their Performance in Healthy Volunteers (\"HEIGHT\" Study)","TERMINATED",[41],"2023-03-27","2023-03-31","2018-04-10",694,[21],[292]]